drugset / Trial / NCT03658876
Predictors of Response to Iron and Erythropoietin Stimulating Agents
RandomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of the study is to identify predictors of treatment response. This involves collected baseline clinical parameters and bloods for biochemical parameters prior to administering the study treatment. A positive outcome following treatment was defined as an uptitration of haemoglobin by greater than 5g/l within 2 months. The study evaluated the participants response to treatment against the clinical and biochemical information collected prior to treatment being received.
Timeline
- Start
- 2015-06-03
- Primary completion
- 2016-12-31
- Completion
- 2017-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iron sucrose | Unknown | 200 mg | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | 0 iu | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | 1000 iu | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | 2000 iu | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | 3000 iu | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | 4000 iu | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | 6000 iu | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | 8000 iu | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | 12000 iu | — |